E-mail a Wiley Online Library Link

Joe Y. Chang, Yung-Hsien Liu, Zhengfei Zhu, James W. Welsh, Daniel R. Gomez, Ritsuko Komaki, Jack A. Roth and Stephen G. Swisher Stereotactic ablative radiotherapy: A potentially curable approach to early stage multiple primary lung cancer Cancer 119

Version of Record online: 24 JUN 2013 | DOI: 10.1002/cncr.28217

The authors review the outcomes of 101 patients who underwent stereotactic ablative radiotherapy (SABR) for metachronous or synchronous multiple primary lung cancer. Excellent rates of local control (95.7% at 4 years), overall survival (47.5% at 4 years and a median overall survival of 46 months), and progression-free survival (58% at 4 years), along with acceptable rates of treatment-related toxicity, make SABR an effective alternative to surgery for patients with early stage multiple primary lung cancer.

Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf

Required = Required Field